Anti-FHL2 Antibody

The FHL2 protein (Four and a Half LIM Domains 2), also known as DRAL, is a multifunctional LIM-only scaffolding protein expressed in cardiac and skeletal muscle and in several other tissues, where it shuttles between the nucleus and cytoplasm and acts as a context-dependent transcriptional co-activator or co-repressor for partners including androgen receptor, AP-1, CREB, NF-κB, and SRF.

This unconjugated rabbit polyclonal IgG reagent from Antibodies.com is raised against FHL2 and validated for Western blot and immunohistochemistry on human, mouse, and rat samples, supporting studies of cardiac development, myogenic differentiation, integrin signalling, and FHL2's roles in tumour biology and related disease contexts.

Supplied as a 100 µl liquid vial in unconjugated format, the reagent allows users to apply their own preferred detection chemistry. The polyclonal rabbit host background supports consistent reactivity across lots for routine immunodetection workflows.